Skip to main content

Table 1 Control region point heteroplasmies detected in more than one person

From: Mitochondrial point heteroplasmy: insights from deep-sequencing of human replicate samples

Mitochondrial (MT) locus

Position

Major allele

Minor allele

Substitution rate [46]

No. Persons

Total no. PHPs (both tissues)

Median MAF*% (MIN% -MAX%)

No. persons reported in [10]

No. mother-child duos reported in [6]

MT-HV2

189

A

G

31

6

7

0.5 (0.3–0.6)

103

3

MT-HV1

16129

G

A

86

6

6

0.2 (0.2–0.6)

1 (5 A>G)

/

MT-HV2

152

T

C

157

5

7

0.2 (0.2–5.1)

10

1

MT-HV1

16293

A

G

17

5

5

0.3 (0.2–0.5)

1

/

Control region

16519

C

T

209

4

6

0.3 (0.1–2.8)

1 (9 T>C)

/

MT-HV2

146

T

C

109

4

4

0.3 (0.1–0.4)

2

/

MT-HV1

16093

C

T

79

3

6

3.0 (1.6–12)

6

3

MT-HV2

204

T

C

43

3

5

0.4 (0.3–2.1)

26

1

MT-HV1

16286

T

C

5

2

4

1.9 (0.9–39.6)

/

/

MT-HV1

16311

T

C

120

2

3

0.5 (0.3–6.8)

/ (2 C>T)

/

MT-HV2

214

A

G

10

2

3

2.3 (0.2–49.6)

/ (2 A>T)

3

Control region

16390

G

A

31

2

3

2.4 (0.1–18.3)

17

/

MT-HV2

195

T

C

98

2

2

2.6 (0.4–4.7)

3

1

  1. * median MAF value was calculated from all MAFs detected at designated positions across buccal and blood samples of 11 individuals
  2. minor allele A
  3. in brackets, number of persons with point heteroplasmy of reverse substitution direction (i.e., where major and minor allele nucleotides are reversed)